James Smith

James is a postdoctoral scientist interested in meta-research, currently focussed on evaluating and improving medical device regulatory pathways.

His MRC funded DPhil was titled “Patent Landscape Reporting Quality and Predicting Drug Approval”, in which he found evidence for poor reporting quality in patent landscapes and developed the reporting items for patent landscapes (RIPL) statement, a reporting guideline.  Hoping to reduce the extremely high costs of drug development, he also developed a predictive model which aimed to predict market approval of small molecule compounds from the pre-clinical stage.

He was previously a Research Associate of the CASMI Translational Stem Cell Consortium, where worked on a variety of projects relating to advanced therapeutics, and was a SENS Research Foundation Summer Scholar at the Harvard Stem Cell Institute. 

James has a first class undergraduate degree in Biological Sciences from the University of Oxford, where he was an academic scholar at Worcester College.